Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 5/20 | 0.53 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.52 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.52 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.52 |
| ▸ | GSK3B | P49841 | 1/20 | 0.51 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.47 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.47 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | DRD1 | P21728 | 1/20 | 0.41 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.41 |
| ▸ | PTPRC | P08575 | 1/20 | 0.41 |
| ▸ | LPL | P06858 | 1/20 | 0.41 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.41 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27743518 | 0.98 | ERN1 (0.51) | ERN1CYP2A6CYP2E1CYP2B6GSK3B | |
| SCHEMBL18002228 | 0.81 | ERN1 (0.51) | ERN1CYP2A6CYP2E1CYP2B6GSK3B | |
| SCHEMBL27989815 | 0.81 | CYP2A6 (0.74) | ERN1CYP2A6CYP2E1CYP2B6GSK3B | |
| SCHEMBL28985375 | 0.78 | CYP2A6 (0.52) | ERN1CYP2A6CYP2E1CYP2B6GSK3B | |
| SCHEMBL25288128 | 0.78 | CYP2A6 (0.58) | CYP2A6DRD1 | |
| SCHEMBL976904 | 0.78 | CYP2A6 (0.58) | CYP2A6DRD1 | |
| SCHEMBL1666706 | 0.78 | CYP2A6 (0.58) | CYP2A6DRD1 | |
| SCHEMBL27335985 | 0.78 | CYP2A6 (0.58) | CYP2A6DRD1 | |
| SCHEMBL18002045 | 0.77 | CYP2A6 (0.62) | ERN1CYP2A6CYP2E1CYP2B6GSK3B | |
| SCHEMBL7523352 | 0.76 | ERN1 (0.51) | ERN1CYP2A6CYP2E1CYP2B6KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119371752-A | Antibacterial packaging material and preparation method thereof | 深圳市国盛新材料科技有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-118085245-B | Thiophene copolymer and preparation method and application thereof | 链行走新材料科技(广州)有限公司 | 2024-07-30 | — | — | CN | claimed |
| CN-118085245-A | Thiophene copolymer and preparation method and application thereof | 链行走新材料科技(广州)有限公司 | 2024-05-28 | — | — | CN | claimed |
| US-9539336-B2 | Sialic acid derivatives | BROSSMER REINHARD (DE) | 2017-01-10 | — | — | US | claimed |
| EP-2863925-B1 | SIALIC ACID DERIVATIVES | BROSSMER REINHARD (DE) | 2016-09-14 | — | — | EP | claimed |
| US-20150174262-A1 | Sialic Acid Derivatives | BROSSMER REINHARD (DE) | 2015-06-25 | — | — | US | claimed |
| US-20140371218-A1 | NOVEL NK-3 RECEPTOR SELECTIVE ANTAGONIST COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN NK-3 RECEPTORS MEDIATED DISORDERS | OGEDA SA (BE) | 2014-12-18 | — | — | US | claimed |
| CN-119371752-A | Antibacterial packaging material and preparation method thereof | 深圳市国盛新材料科技有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-119371752-A | Antibacterial packaging material and preparation method thereof | 深圳市国盛新材料科技有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-118085245-B | Thiophene copolymer and preparation method and application thereof | 链行走新材料科技(广州)有限公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-118085245-B | Thiophene copolymer and preparation method and application thereof | 链行走新材料科技(广州)有限公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-118085245-A | Thiophene copolymer and preparation method and application thereof | 链行走新材料科技(广州)有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-118085245-A | Thiophene copolymer and preparation method and application thereof | 链行走新材料科技(广州)有限公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2010075356-A1 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2010-07-01 | — | — | WO | disclosed |
| US-20100160323-A1 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2010-06-24 | — | — | US | disclosed |
| US-20100160323-A1 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2010-06-24 | — | — | US | disclosed |
| US-20100160323-A1 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2010-06-24 | — | — | US | disclosed |
| WO-2006047167-A2 | 9 ALKYL AND 9 ALKYLIDENYL 6-0 ALKYL-11, 12 CARBAMATE KETOLIDE ANTIMICROBIALS | JANSSEN PHARMACEUTICA, N.V. (BE) | 2006-05-04 | — | — | WO | disclosed |
| EP-0784612-A1 | UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-07-23 | — | — | EP | disclosed |
| WO-1996010559-A1 | UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140371218-A1 | NOVEL NK-3 RECEPTOR SELECTIVE ANTAGONIST COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN NK-3 RECEPTORS MEDIATED DISORDERS | ACKR3, BDKRB2, GPR3 | ERN1 2748/4885CYP2A6 3023/4885CYP2E1 3863/4885 |
| US-20100160323-A1 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE | SCD, SCD5, FADS2 | ERN1 3496/4885CYP2A6 1654/4885CYP2E1 1363/4885 |
| US-20150174262-A1 | Sialic Acid Derivatives | NEU1, SIGLEC9, SIGLEC7 | ERN1 1413/4885CYP2A6 1018/4885CYP2E1 2764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.